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1. Introduction 
Bone marrow (BM) is a complex tissue containing populations of progenitor and stem cells 
(1). One type, hematopoietic stem cells (HSCs), can renew circulating blood elements such 
as red blood cells, monocytes, platelets, granulocytes and lymphocytes. The other is 
mesenchymal stem cells (MSCs), which possess two important properties of long-term self 
renewal and differentiate into osteoblasts, chondroblasts, adipocytes and hematopoiesis 
supporting stroma (2, 3). Their mesenchymal differentiation potential is retained even after 
repeated subcultivation in vitro (4, 5). Besides originating the forming mesenchymal tissue, 
many studies have demonstrated that MSCs could differentiate into various non-
mesenchymal tissue lineages under appropriate experimental conditions in vitro and in vivo, 
such as hepatocytes (6, 7), cardiomyocytes (8, 9), lung alveolar epithelium (10), olfactory 
epithelium (11), inner hair cells (12), neurons and neuroglia (1, 4, 13). MSCs are spindle 
shaped fibroblast-like cells that are easily isolated, cultured and expanded in vitro due to 
their adherent characteristics, and not associated with any ethical debate (14). Thus, MSCs 
may be used in the treatment of a diverse variety of clinical conditions (15) such as 
engraftment of various organs (16). The long-term cultivation of MSCs may fail for many 
reasons: genotypic drift, senescence, transformation, phenotypic instability, and 
contamination or incubator failure. The inability to cultivate MSCs will result in the lack of 
MSCs for both experimental and clinical use (17). Therefore, it is necessary to cryopreserve 
MSCs as cell seeds. Although increasing telomerase expression of cells may overcome cell 
senescence (18), cryopreservation of hMSCs may be more practical in order to save time and 
culture materials (16, 19). Resuscitated MSCs can be subcultivated for many passages 
without a noticeable loss of viability and capability of osteogenic differentiation (20-22). 
Formulating a cryopreservation protocol for hMSCs is required because these cells cannot 
survive for long periods under in vitro culture conditions. Slow rate cooling methods using 
dimethylsulfoxide (DMSO) as a cryoprotectant have been used for a wide variety of MSC 
lines established from bone marrow (23, 24), umbilical cord blood (23-25), hematopoietic 
progenitor  cells (26) and mouse ES cell lines (27). In most protocols, cells are suspended in 
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freezing medium containing DMSO at 5-20%, transferred into glass or plastic cryovials and 
then frozen by cooling at 1.0 to 2.0 °C/min (28). Slow freezing reduces ice crystal formation 
and eliminates toxic and osmotic damage to cells through exposure to low concentrations of 
cryoprotectants while slowly decreasing temperatures (29). However, it is difficult to 
completely eliminate injury by intracellular ice formation. Damage by ice crystal formation 
in the cytoplasm during the freezing process is one of the possible causes of cell death; such 
conventional methods, are not applicable to hMSC cells because many of these cells die 
immediately after thawing (28). Alternately, vitrification, a rapid cooling method using a 
high concentration of cryoprotectant, could also be used. Vitrification can completely 
eliminate damage caused by ice crystal formation in the cytoplasm of cells during freezing 
(29, 30). It is also advantageous because the procedure takes a relatively short time and a 
programmable temperature decreasing container is not required (31). 
Vitrification has been used for the cryopreservation of oocytes, fertilized eggs and embryos 
of several mammalian species including humans in order to prevent ice crystal formation 
(32). There have been some reports demonstrating that embryonic stem (ES) cells could be 
successfully cryopreserved by vitrification in recent years (27, 33,34). Moon et al. tested 
vitrification of the human amnion-derived mesenchymal stem cells (HAMs) by using a two-
step exposure to equilibration and vitrification solutions (21). They used an EG-based 
cryoprotectant and their findings were in line with previous reports that showed the 
superiority of EG. EG has been proven to be less toxic on fibroblast and other somatic cells 
in comparison with permeating agents such as DMSO and propylene glycol (PROH) that 
have been used on murine and human embryos (35). However, as a long-term preservation 
method for HAMs, a well-defined protocol of cryopreservation needs to be established for a 
human bone marrow derived mesenchymal stem cell bank. In the present study, to confirm 
the proliferative capability and pluridifferentiation of cryopreserved adult hMSCs; we chose 
ethylene ficoll sucrose (EFS) 40 that contained 40% v/v EG for the vitrification solution. 
hMSCs that were cryopreserved for two months were resuscitated and cultivated for 15 
passages. An analysis of their expansion, morphological and pluridifferentiation 
characteristics was undertaken. Finally, under induction conditions, adipogenic and 
osteogenic potentials have been discussed. 
2. Materials and methods 
2.1 Preparation and culture of MSCs 
For isolation of rat MSCs; female Sprague-Dawley rats (weighing 200-250 g) with the 
approval from the Institute for Animal Care were obtained from the Animal Center, Faculty 
of Medicine, Guilan University of Medical Sciences. Rats were killed by intraperitoneal 
administration of a lethal dose of sodium pentobarbital. The femurs and tibias were 
carefully dissected away from attached soft tissue as previously reported with modification 
(1). The ends of the bones were cut, and the bone marrow was aseptically extruded with 5 
ml PBS solution by using a syringe with a 21G needle and flushing the shaft ten times. The 
marrow tissue was dissociated by pipetting. The cell suspension was then centrifuged at 500 
× g for 5 minutes and the supernatant was discarded. Bone marrow mesenchymal stem cells 
(BMSCs) were then mechanically dispersed into a single-cell suspension so that the density 
of BMSCs reached 106 cells/ml. At this point, marrow cells were plated in a 25 cm² plastic 
flask in Dulbecco’s modified eagle medium (DMEM) containing 20% fetal bovine serum 
www.intechopen.com
Cryopreservation of Rat Bone Marrow Derived Mesenchymal  
Stem Cells by Two Conventional and Open-Pulled Straw Vitrification Methods 
 
5 
(FBS), 100 U/ml penicillin, and 100 mg/ml streptomycin. All cells were incubated at 37 °C, 
in an atmosphere of 5 % humidified CO2. After 48 hours incubation, the nonadherent cell 
populations were removed and the medium was added and replaced every three or four 
days for about two weeks. When the cells grew to 80% confluency they were harvested with 
0.25% trypsin and 1 mM EDTA (Gibco, UK) for 5 minutes at 37°C, replated and diluted 1:3 
on a 25 cm² plastic flask, again cultured to the next confluency and harvested. Prior to their 
use in inducing differentiation and vitrification MSCs that were passaged approximatly 15 
times were morphologically evaluated. 
2.2 Cryopreservation of MSCs 
MSCs at passage 4 of pre-cryopreservation were harvested and centrifuged at 400 × g for 15 
minutes as mentioned above. Approximately 1 ×106 cells/ml of randomly selected batches 
were cryopreserved by using the vitrification method or OPS vitrification. 
2.3 Vitrification and thawing procedure 
MSCs were cryopreserved by using a two-step exposure to the equilibration and 
vitrification solutions (34). The equilibration solution was 20% ethylene glycol (EG; Sigma) 
and the vitrification solution was composed of 40% EG, 18% Ficoll - 70 (Sigma) and 0.3 M 
sucrose (Sigma). All solutions were based on PBS (Sigma) containing 20% FBS. A pellet of ~1 
× 106 MSCs (~10 μl) was first suspended in 50 μl equilibration solution for 5 minutes and 
then mixed with 500 μl vitrification solution for 40 seconds. Suspended MSCs were 
immediately transferred to 1.2 ml cryovials (Nunc) and plunged directly into liquid 
nitrogen. The OPS vitrification method was carried out according to Reubinoff et al. (33). For 
OPC, a pellet of ~1 × 106 MSCs (~10 μl) was first suspended in 50 μl equilibration solution 
for 5 minutes and then mixed with 500 μl vitrification solution for 40 seconds. Suspended 
MSCs were at once transferred to 0.25 ml plastic straws (IMV, L’Aigle, France). Immediately 
afterwards, the straws were immersed in liquid nitrogen for two months. Following storage, 
the cells were thawed by rapidly immersing the vials and straws in a water bath at 37 °C. 
After warming for about 7 seconds, (at approx. 1800 °C/min) the contents of the vials and 
straws were suspended serially in 0.5, 0.25 and 0 M sucrose in PBS containing 20% FBS. 
After thawing, the survival rate was evaluated by the trypan blue staining method. After 
removing some of the cell pellet and adding 0.4% trypan blue (Sigma), the cells were plated 
onto a slide and unstained cells were counted as live cells (26). The remaining cells were 
centrifuged at 200 × g for 10 minutes and washed three times with DMEM medium 
supplemented with 20% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were 
immediately plated at a density of 1 × 106 cells/ml in a 25 cm2 culture flask and subcultured 
over seven days in the above described condition.  
2.4 Evaluation of the differentiation potential of cryopreserved MSCs 
2.4.1 Adipogenic induction 
Pre and post-cryopreserved MSCs were seeded on coverslips in a six-well plate and 
cultured in DMEM with 10% FBS. Cells with nearly 80% confluency were exposed to DMEM 
supplemented with 5μg/ml insulin, 1 μM dexamethasone, 100 nM indomethacine, 0.5 mM 
methylisobutylxanthine (Sigma), and 10% FBS for 48 hours. Cells were then incubated in the 
same medium without dexamethasone. For control, cells were cultured in regular medium 
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as above. The medium was changed every third or fourth day. One week after induction, 
adipogenic differentiation was evaluated by the cellular accumulation of neutral lipid 
vacuoles that were stained with oil-red O (Sigma) and observed under an inverted 
microscope (17). Briefly, after fixation in 5% metanol, induced MSCs were stained in filtered 
oil red O for 2-3 hours and then rinsed with 60% isopropyl alcohol. 
2.4.2 Osteogenic induction 
To identify osteogenic differentiation, thawed and non-cryopreserved MSCs were cultured 
in 100 nM dexamethasone, 10 mM ß-glycerol phosphate and 50 μM ascorbic acid-2-
phosphate in 400 μl DMEM-LG supplemented with 10% FBS on coverslips in a six-well plate 
for subsequent staining. During the culture period, the medium was changed once per 
week. After 14 days, osteogenic differentiation was evaluated by staining the coverslips with 
fresh 0.5% alizarin red solution (1). 
2.4.3 Colony-forming unit assays 
For these assays, both thawed and non-cryopreserved cells were plated at 1 × 106 cells per ml 
and cultured for 14 days in 25 cm² tissue culture flasks. After 14 days, the cultures were stained 
with giemsa for 5 minutes. The formations of colonies were considered acceptable until 
passage 15 (P15) and those less than 2 mm in diameter or faintly stained were excluded. 
2.4.4 Statistical analysis 
Statistical analysis for comparison of the postthaw survival rate was performed using the χ2 
test. Statistically significant values were defined as p<0.05. All experiments were conducted 
in triplicate. 
3. Results 
The growth and morphology of MSCs appeared rather heterogeneous in primary culture as 
seen in Fig 1A. Under a phase contrast microscope, the cells appeared fibroblast-like, 
elongated and spindle shaped with a single nucleus (Fig 1B). These cells showed the ability 
to form colonies with the occasional cell sphere formation giving an impression of embryoid 
bodies (Fig 1C). However, they progressively showed homogenous fibroblast-like features 
following subsequent subculture (Fig 1D). 
3.1 Morphology and growth of vitrified-thawed MSCs 
The duration of storage in frozen state for MSCs was two months. Post-cryopreserved MSCs 
from both the vitrification method and OPS vitrification had similar cellular morphology 
and colony-formation. Resuscitated MSCs first grew as isolated colonies after initial plating. 
Subsequently these adherent cells grew as typically fibroblastic or spindle shaped. 
As the cells approached confluence, they assumed a more spindle-shaped, fibroblastic 
morphology (Fig 2A, B). The thawed and non-cryopreserved MSCs were subcultured until 
P15. Until the P9, fibroblast-like morphology was consistently observed in both the thawed 
and non-cryopreserved MSCs. At the P10, cells in both cultures became large and flat, 
suggesting senescence. 
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Fig. 1. Morphology and growth of MSCs. (A) Primary (x 40), (B) Passage 4 (14 days, x 100), 
(C) Passage 4 (35 days, x 100) and (D) Passage 4 (40 days, x 100). In primary culture, cell 
growth was scattered with some colony formation. Followin subsequent subculture, the 
cells changed into spindle-like fibroblasts. 
  
Fig. 2. Morphology and growth of vitrified-thawed MSCs. Phase contrast images of MSCs 
two months after thawing from: (A) vitrification method (x 100) and (B) OPS vitrification (x 
40). MSCs had a similar morphology to fibroblasts and were indistinguishable from non-
cryopreserved MSCs. 
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4. Viability of vitrified-thawed MSCs 
Live/dead viability of MSCs was determined by the trypan blue staining test. The number 
of MSCs was counted and compared to that of the control. After thawing, the viability rates 
were 81.33% ± 6.83 for the vitrification method and 80.83% ± 6.4 for the OPS vitrification, 
while values with the pre-vitrification control group were 88.16% ± 6.3, respectively (Table 
1). There were no differences in viability between them. 
 
No. 
Before vitrification  
(%) 
Vitrification method  
(%) 
OPS method  
(%) 
1 85 81 82 
2 93 92 90 
3 78 77 70 
4 96 81 79 
5 89 72 81 
6 88 85 83 
Mean ± SD 88.16(SD ± 6.30) 81.33 (SD ± 6.83) 80.83(SD ± 6.40) 
OPS: open-pulled straw, student t-test (p<0.05). 
Table 1. Percentage of cell viability of non-cryopreserved and two different cryopreserved 
vitrification methods by the trypan blue staining test. 
5. Colony forming unit assay 
For these assays, cells of both thawed and noncryopreserved MSCs or cultures were plated 
at 1× 106 cells/ml and MSCs in culture showed a colony formation consisting of 40-80 cells 
in 25 cm² flasks for 14 days (Fig 3). After P9, the cells showed no colony forming ability 
which illustrated that colony forming ability decreases with increasing passages. 
 
  
Fig 3. Phase contrast images of typical MSCs colony morphology before (A) and after (B) 
cryopreservation. Cell sphere formation in the MSCs culture produced colony formation 
units that stained with giemsa (A and B: x 40). 
www.intechopen.com
Cryopreservation of Rat Bone Marrow Derived Mesenchymal  
Stem Cells by Two Conventional and Open-Pulled Straw Vitrification Methods 
 
9 
6. Differentiation of post-cryopreserved MSCs 
After culturing for adipogenic differentiation, the accumulations of numerous neutral lipid 
vacuoles were detectable in the cytoplasm of vitrified-thawed cells (Fig 4A). Following three 
weeks of induction, oil Red O staining showed the lipid droplets with orange red color, 
which demonstrated the committed differentiation of MSCs into adipocytes (Fig 4B). The 
control cells showed no detectable lipid vacuoles. Under culture with osteogenic induction 
medium, resuscitated MSCs detached and floated in the medium. After three weeks, 
mineral accumulations were observed by alizarin red staining (Fig 5A, B). Similar results 
were observed in the group of non- cryopreserved MSCs when osteogenically induced 
under the same condition (Fig 5C, D). 
  
Fig 4. Evaluation of adipogenesis potential of MSCs under a phase-contrast microscope. 
Both the non cryopreserved MSCs and vitrified-thawed MSCs after treatment by adipogenic 
medium showed numerous neutral lipid vacuoles which accumulated in the cytoplasm. (A) 
Confirmed by oil red O staining (oil red O + hematoxiline, which one is the top right one: oil 
red without hematoxiline, x 100), (B). 
7. Discussion 
Cryopreservation is an important method to maintain cells for biological research and 
medical applications such as tissue engineering, gene therapy, cell transplantation, 
pharmacological testing and future therapeutic indications (17, 28). A study on the long-
term storage of BM-derived MSCs is of critical importance (1). The objective of the current 
investigation was to test the possibility that vitrification could be a useful method for the 
cryopreservation of MSCs. Thus, in the present study, we isolated MSCs from bone marrow 
of adult female rats. In culture; MSCs are characterized by their capacity to adhere to a 
plastic culture surface and form a fibroblast-like shape (Fig 1). Our data corroborated 
previous findings from other groups which showed homogenous fusiform features with 
oval vesicular nuclei (36) and the colony forming ability of MSCs, which decreased with 
increasing passages (37). The achievement of pure fibroblastic clones from murine bone 
marrow was first reported by Wang and Wolf (38). 
Furthermore, Eslaminejad et al. obtained an average of 15-17 clones, each one consisting of 
several fibroblastic cells per 24-well plate (39). This approach yielded both the number and  
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Fig 5. Differentiation potency of nonvitrified and vitrified-thawed MSCs observed under a 
phase-contrast microscope. (A) Nonvitrified MSCs after osteogenic induction. (B) Alizarin 
red staining, x 100. (C) Vitrified MSCs after osteogenic induction. (D): Alizarin red staining, 
x 100. After induction of differentiation for 2-3 weeks in respective induction media, the 
mineralized extracellular matrix of pre and post-vitrification MSCs stained positively with 
alizarin red (arrows). 
cellular densities of colonies that were dependent upon the number of the cells plated per 
culture dish and was the method employed in this investigation. We also successfully 
vitrified MSCs and confirmed the morphology, viability rate and differentiation capacity of 
post-vitrification MSCs as compared with non-cryopreserved controls. Generally, most 
comprehensive studies on the cryopreservation of MSCs were carried out by using slow-rate 
cooling methods (17, 22-24). Slow-rate cooling methods using dimethylsulfoxide (DMSO) as 
a cryoprotectant are effective for a wide variety of cell lines, including ES cell lines (27, 28). 
This method by decreasing temperature slowly with a low concentration of cryoprotectant is 
used to balance damage caused by various factors including ice crystal formation, fracture, 
toxic and osmotic damage (29). 
It is difficult to completely eliminate injuries from intracellular ice formation, which is the 
main source of fracture and damage to the cytoplasm (29). It is also a time-consuming 
procedure and requires an expensive programmable freezer (31). On the other hand, there 
are some reports that stem cells are highly sensitive to cryoinjury and the vitrification 
method is a better choice for HES cell cryopreservation than conventional slow freezing and 
rapid thawing (28, 33). This method has been previously applied for cryopreservation  
of oocytes, fertilized eggs and embryos of several mammalian species, including humans 
(32).  
www.intechopen.com
Cryopreservation of Rat Bone Marrow Derived Mesenchymal  
Stem Cells by Two Conventional and Open-Pulled Straw Vitrification Methods 
 
11 
In vitrification method, the concentrations of cryoprotectants seem to be dangerously high at 
the final phases, it happens at low temperatures, where the real toxic effect is minimal. 
Moreover, the high cooling and warming rates applied at vitrification provide an unique 
benefit compared to the traditional freezing (40). 
Umbilical cord blood-derived mesenchymal stem cells (UCB-derived MSCs) were vitrified 
by vitrification and by programmed freezing without dimethyl sulfoxid (DMSO) by Wang et 
al. (2011). Their results showed that the viability of thawed UCB-derived MSCs was 
enhanced from 71.2% to 95.4% in the presence polyvinyl alcohol (PVA) for vitrification, but 
only < 10% to 45% of viability was found for programmed freezing (41). While, Kim et al. 
reported that Post-thaw colony-formation of embryonic stem cells (ESCs) was detected only 
after a slow freezing using DMSO by stepwise placement of a freezing container into a -80°C 
deep freezer and subsequently into -196°C liquid nitrogen, while no proliferation was 
detected after vitrification (42). Also, hMSCs from pre- and post-cryopreservation by slow 
freezing had similar colony-formation and cellular morphology similar to our resuls (17). 
Low survival of human ESCs has been also reported when they are frozen slowly with 
DMSO (43). There have been several reports to demonstrate the superiority of vitrification to 
other freezing programs for human ESCs, because it is able to avoid cell injury resulted from 
ice crystal formation (42, 44).Carvalho et al. (2008) reported that viability of frozen BM-
MSCs by slow freezing which was to added 5% DMSO was 94.76% and 90.58% viability 
before versus after cryopreservation (45). Also, the high survival rate (81.8%) is obtained 
after cryopreservation of human ESCs by programmed freezing (46). Our result showed 
81.33% and 80.83% cell viability of two different cryopreserved vitrification methods versus 
88.16% viability of non-cryopreserved cells. Nevertheless, we are not able to deny the 
feasibility of vitrification program for effective cryopreservation of SCs (42). 
Also Fujioka et al. vitrified ESCs using EFS40; ethylene glycol, 18% ficoll 70,000 MW and 0.3 
M sucrose (similar to this work) and slow-freezed in freezing medium containing 10% 
DMSO. Their results indicated that the vitrification methods yielded higher cell recovery 
and survival rates than did the slow-rate freezing methods (28).   
DMSO has been well known as a toxic agent for stem and progenitor cells, and particularly 
for human embryonic stem cells. It is also known as a powerful differentiation agent that 
may interact with the chromatin structure (47). 
Therefore, the selection of suitable cryoprotectants is essential. Cryopreservation procedure 
ought to become different according to cell type and cellular characteristics. So, all 
components consisting of freezing and thawing procedures should specifically be 
determined in each case of cryopreservation (42). 
This study was DMSO-free vitrification of MSCs using cryovial and straw. Straws, 
preferably thin straws, even in sealed form, can be cooled safely with an increased cooling 
rate (40). There was any report about vitrification of MSCs without DMSO.   
So that in the present experiment, we have observed the viability and proliferation 
capability as well as differentiation potential of cryopreserved MSCs in vitro. Inverted 
microscope findings showed that, after culturing for seven days, numerous MSCs adhered 
well to the surface culture dish (Fig 1). In a study by Moon et al. on human amnion-derived 
mesenchymal stem cells (HAMs), they observed that slow freezing resulted in a lower 
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survival rate compared with vitrification, indicating a high efficiency of the vitrification 
procedure (21). 
Moreover, Heng (48) demonstrated that 39.8 ± 0.9% of the hMSCs could be recovered after 
cryopreservation using a conventional slow freezing method which was lower than that our 
result (Table 1). Here, resuscitated MSCs kept a high proliferative potential. They first grew 
as clones after limiting dilution and then expanded rapidly with the typical features of 
spindle-shaped cell bodies and confluence after a lag phase of 6-14 days. There were no 
differences among the pre and post-cryopreservation of colony formation at the same 
passage (Fig 2). In addition, the results showed that the passage procedure was selective for 
MSCs and it could be inferred that the passaging of resuscitated MSCs increased cellular 
homogeneity.  
Ji et al. demonstrated that cryopreservation of encapsulated HES cells offers better cellular 
viability, higher colony recovery, and less differentiation than the slow-freezing techniques 
most commonly used to preserve HES colonies. Therefore, this difference in recovery may 
be due to differences in cell lines, freezing and thawing protocols, or growth substrate (49). 
On the other hand, previous studies have shown that cyropreservation had no effect on 
either the proliferation or osteogenic and adipogenic differentiation of human MSCs in vitro 
(5, 22). In agreement with these reports, Liu et al. using slow cooling with Me2SO as a 
cryoprotectant and rapid thawing demonstrated that thawed cryopreserved human MSCs 
had higher survival rates in comparison with non-cryopreserved MSCs and differentiated 
into osteoblasts when cultured in osteogenic media. Also they found that cryopreserved 
hMSCs could not differentiate into osteoblasts spontaneously when cultured in basic culture 
media (50). In addition to the characteristics described above, our present study 
demonstrated that post-cryopreserved MSCs from bone marrow were still pluripotential 
and differentiated into osteoblasts and adipocyte under appropriate culture conditions (Fig 
3, 4). These observations suggest that the "memory" of proliferation and differentiation in 
MSCs is not affected by the process of vitrification. The ability of frozen BM-MSCs by slow 
freezing to differentiate into mesenchymal derivatives (such as osteogenic and adipogenic) 
reported by Lee et al. (4).  In this study, we established a two-step vitrification protocol for 
MSCs using EFS containing 40% v/v EG for the vitrification solution, which is widely used 
for successful vitrification of mouse embryos (30), human blastocysts (32) and ESCs (34). 
Our findings are in line with the reports by Gajda et al. who used the same methods for 
somatic cells which have been proven to be less toxic on bovine skin fibroblast and cumulus 
cells (35).  
EG is the most commonly used cryoprotectant for vitrification due to its low molecular 
weight and low toxicity (35). In addition, additives with high molecular weights, such as 
sucrose, can significantly reduce toxicity by decreasing the concentration of permeating 
agents required for the vitrification solution. We also used ficoll as a macromolecule to 
promote permeation by cryoprotectants, which seems to have the advantages of lower 
toxicity, higher solubility and lower viscosity (30). In a study by Moon et al. on HAMs, they 
observed that the combination of EG with either PROH or DMSO resulted in a very low 
survival rate of HAMs as compared with EFS alone (21). Also, Kuleshova and Lopata 
ascertained the advantages of vitrification when compared with earlier applied 
cryopreservation techniques (51). These advantages include the control of solute penetration 
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and dehydration rates, prevention of prolonged temperature shock and damage from ice 
formation, and inexpensive equipment and running costs. Vitrification is a process where 
glass-like solidification of a solution occurs without the formation of ice crystals inside 
living cells, by exposure to a high concentration of cryoprotectant with a higher cooling rate 
(52). This procedure is a simple method to circumvent the obstacles of slow freezing without 
the need for a freezing container to modulate the reduction of temperature in a deep freezer 
before storing in liquid nitrogen (21). 
8. Conclusion 
In the present experiment, it was shown that vitrification can be an efficient storage method 
for MSCs without losing their activity and usual properties. Such a system will be 
exceedingly helpful for both experimental research and medical applications. 
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